Biology of the Interleukin-9 Pathway and its Therapeutic Potential for the Treatment of Asthma
Inflammation & Allergy - Drug Targets · 01.06.2011 · 10 (3) · 180-186
DOI: 10.2174/187152811795564073 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Inflammation & Allergy - Drug Targets, erschienen am 01.06.2011. Verfasst von Chad K Oh und 3 weiteren Autor:innen. Beteiligte Einrichtung: MedImmune, LLC, One MedImmune Way, Gaithersburg, MD 20878, USA. molfinon@medimmune.com. Hauptthemen laut MEDLINE: Immunotherapy. Die Arbeit wurde bisher 35-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MedImmune, LLC, One MedImmune Way, Gaithersburg, MD 20878, USA. molfinon@medimmune.com.
Zitieren
APA
Oh, C. K., Raible, D., Geba, G. P., & Molfino, N. A. (2011). Biology of the Interleukin-9 Pathway and its Therapeutic Potential for the Treatment of Asthma. Inflammation & Allergy - Drug Targets, 10(3), 180-186. https://doi.org/10.2174/187152811795564073
Vancouver
Oh CK, Raible D, Geba GP, Molfino NA. Biology of the Interleukin-9 Pathway and its Therapeutic Potential for the Treatment of Asthma. Inflammation & Allergy - Drug Targets. 2011;10(3):180-186. doi:10.2174/187152811795564073
BibTeX
@article{Oh2011,
author = {Oh, Chad K and Raible, Donald and Geba, Gregory P and Molfino, Nestor A},
title = {Biology of the Interleukin-9 Pathway and its Therapeutic Potential for the Treatment of Asthma},
journal = {Inflammation & Allergy - Drug Targets},
year = {2011},
volume = {10},
number = {3},
pages = {180--186},
doi = {10.2174/187152811795564073}
}
EUVIMED